Canopy Growth (CGC)
(Delayed Data from NSDQ)
$6.21 USD
+0.07 (1.14%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $6.20 -0.01 (-0.16%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Price, Consensus and EPS Surprise
CGC 6.21 +0.07(1.14%)
Will CGC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CGC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CGC
Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know
Canopy Growth Corporation (CGC) Reports Q1 Loss, Lags Revenue Estimates
CGC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Rockwell Medical (RMTI) Tops Q2 Earnings and Revenue Estimates
Quipt Home Medical Corp. (QIPT) Reports Next Week: Wall Street Expects Earnings Growth
Canopy Growth Corporation (CGC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Other News for CGC
Introducing Wanderous by Wana, a New Online Marketplace for Direct-to-Consumer Hemp-Derived THC and CBD Products
Rising High: Clearmind granted patent approval for binge behavior treatment
Bullish Monday For Marijuana Stocks - Leafbuyer Techs, Pharmadrug Among Top Gainers
Canopy Growth CEO Departure Leaves Nasdaq-Listed Company Poised For Profit Surge - What Investors Need To Know
Industrial Hemp's $14B Projected Growth: An Investment Opportunity Too Good To Miss